Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 346

1.

Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.

Strobl JS, Cassell M, Mitchell SM, Reilly CM, Lindsay DS.

J Parasitol. 2007 Jun;93(3):694-700.

PMID:
17626366
3.

Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer.

Kulp SK, Chen CS, Wang DS, Chen CY, Chen CS.

Clin Cancer Res. 2006 Sep 1;12(17):5199-206.

4.
5.

Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.

Codd R, Braich N, Liu J, Soe CZ, Pakchung AA.

Int J Biochem Cell Biol. 2009 Apr;41(4):736-9. doi: 10.1016/j.biocel.2008.05.026. Epub 2008 Aug 3. Review.

PMID:
18725319
6.

Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.

Han SB, Lee JK.

Arch Pharm Res. 2009 Apr;32(4):613-24. doi: 10.1007/s12272-009-1418-4. Epub 2009 Apr 29.

PMID:
19407980
7.

Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.

Shinji C, Maeda S, Imai K, Yoshida M, Hashimoto Y, Miyachi H.

Bioorg Med Chem. 2006 Nov 15;14(22):7625-51. Epub 2006 Jul 31.

PMID:
16877001
8.
9.

Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.

Strobl JS, Seibert CW, Li Y, Nagarkatti R, Mitchell SM, Rosypal AC, Rathore D, Lindsay DS.

J Parasitol. 2009 Feb;95(1):215-23. doi: 10.1645/GE-1608.1.

PMID:
18837587
10.

Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.

Dubois F, Caby S, Oger F, Cosseau C, Capron M, Grunau C, Dissous C, Pierce RJ.

Mol Biochem Parasitol. 2009 Nov;168(1):7-15. doi: 10.1016/j.molbiopara.2009.06.001. Epub 2009 Jun 16.

PMID:
19538992
11.

Hydroxamide derivatives of short-chain fatty acids are potent inducers of human fetal globin gene expression.

Skarpidi E, Cao H, Heltweg B, White BF, Marhenke RL, Jung M, Stamatoyannopoulos G.

Exp Hematol. 2003 Mar;31(3):197-203.

PMID:
12644016
12.

Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.

Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O.

Eur J Haematol. 2006 Jan;76(1):42-50.

PMID:
16343270
13.

Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors.

Tischler JL, Abuaita B, Cuthpert SC, Fage C, Murphy K, Saxe A, Furr EB, Hedrick J, Meyers J, Snare D, Zand AR.

J Enzyme Inhib Med Chem. 2008 Aug;23(4):549-55. doi: 10.1080/14756360701715703 .

PMID:
18608778
14.

MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells.

Imesch P, Dedes KJ, Furlato M, Fink D, Fedier A.

Int J Oncol. 2009 Sep;35(3):631-40.

PMID:
19639184
15.

Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells.

Dagtas AS, Edens RE, Gilbert KM.

Int Immunopharmacol. 2009 Oct;9(11):1289-97. doi: 10.1016/j.intimp.2009.07.012. Epub 2009 Aug 5.

PMID:
19664724
16.

Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia.

Romanski A, Bacic B, Bug G, Pfeifer H, Gul H, Remiszewski S, Hoelzer D, Atadja P, Ruthardt M, Ottmann OG.

Haematologica. 2004 Apr;89(4):419-26.

17.

Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases.

Gu W, Nusinzon I, Smith RD Jr, Horvath CM, Silverman RB.

Bioorg Med Chem. 2006 May 15;14(10):3320-9. Epub 2006 Jan 24.

PMID:
16434199
18.

Schistosoma mansoni: developmental arrest of miracidia treated with histone deacetylase inhibitors.

Azzi A, Cosseau C, Grunau C.

Exp Parasitol. 2009 Mar;121(3):288-91. doi: 10.1016/j.exppara.2008.11.010. Epub 2008 Dec 6.

PMID:
19094990
19.

Identification of novel isoform-selective inhibitors within class I histone deacetylases.

Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, Johanson K, Liu R, Lago A, Hofmann G, Macarron R, de los Frailes M, Perez P, Krawiec J, Winkler J, Jaye M.

J Pharmacol Exp Ther. 2003 Nov;307(2):720-8. Epub 2003 Sep 15.

20.

Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.

Sekhavat A, Sun JM, Davie JR.

Biochem Cell Biol. 2007 Dec;85(6):751-8.

PMID:
18059533

Supplemental Content

Support Center